BioActor
VC Fund
Maastricht, The Netherlands
BioActor is a VC fund in Maastricht focused on Wellness and Health Care. BioActor develops proprietary health ingredients for use in functional foods, medical nutrition and dietary supplements. All these ingredients address chronic health concerns, such as diabetes,osteoporosis, cardiovascular disease, that would benefit from preventative measures through the diet. BioActor's product development strategy relies onthree simple tenets: a new health ingredient must be based on a patentable scientific discovery; it must be food grade from a natural and renewable source; and its health effect must be clinically proven. BioActor's first product, BONOLIVE, a first in class bone health ingredient that is clinically proven to stimulate bone producing cells, is a great example of this strategy and will be launched in the USA this year. BioActor successfully implemented its product development strategy by establishing alliances with top nutrition research institutes (e.g. INRA, CSIC, Maastricht University, UCL, Ghent University) and by establishing production partnerships with industrial players to shorten the path to market.
- Total investments:
- 1
- Last investment:
- Lead investor:
- 0%
Last updated:
For AI agents: llms.txt
Industries BioActor invests in
Stages BioActor invests in
Countries BioActor invests in
Contacts
| Name | Phone | Socials | |
|---|---|---|---|
1 more contact available
Investment Focus
Industry
- Wellness 1 (100%)
- Health Care 1 (100%)
- Biotechnology 1 (100%)
Team
| Name | Title | Investments | Links | |
|---|---|---|---|---|
Hans van der Saag
Chief Executive Officer
|
Chief Executive Officer | Total investments: 1 | Find email | |
|
Ariel Changyun Zhang
Business Development Manager for Asia Region
|
Business Development Manager for Asia Region | Total investments: 0 | Find email | |
Kevin Wilson
Commercial Manager of Health and Nutrition for Europe, Middle East, and Asia and North America
|
Commercial Manager of Health and Nutrition for Europe, Middle East, and Asia and North America | Total investments: 0 | Find email | |
Yala Stevens
Head of Clinical Research
|
Head of Clinical Research | Total investments: 0 | Find email |
Investments
| Company | Description | Round | Links |
|---|---|---|---|
NapiFeryn BioTech
|
NapiFeryn BioTech extracts protein from rapeseed oil production waste streams for functional, nutritional, and cost-effective protein isolates and concentrates. These ingredients are a sustainable alternative to animal-derived proteins, are nutritional, and can be used in a wide variety of applications | $2.7M / Venture - Series Unknown / Jan 30, 2023 |
Co-Investors
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar industry
Featured in Investor Lists
Recommended lists
FAQ
What does BioActor invest in?
BioActor invests primarily in Wellness, Health Care and Biotechnology startups, most often at Venture - Series Unknown stage. Most of the 1 investments tracked by Shizune back companies in Poland. The Investment Focus section breaks down every industry, stage and country in the portfolio.
How do I contact BioActor?
Public channels for BioActor include LinkedIn and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
Who are the partners at BioActor?
The team at BioActor includes Hans van der Saag (Chief Executive Officer), Ariel Changyun Zhang (Business Development Manager for Asia Region) and Kevin Wilson (Commercial Manager of Health and Nutrition for Europe, Middle East, and Asia and North America). The Team section lists each member with their title, investment count and links.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
